How antirheumatic drugs protect joints from damage in rheumatoid arthritis

Arthritis Rheum. 2008 Oct;58(10):2936-48. doi: 10.1002/art.23951.

Authors

Georg Schett¹, Christian Stach, Jochen Zwerina, Reinhard Voll, Bernhard Manger

Affiliation

¹ Department of Internal Medicine III, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany. georg.schett@uk-erlangen.de

PMID: 18821703
DOI: 10.1002/art.23951

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Antirheumatic Agents / pharmacology
Arthritis, Rheumatoid / drug therapy*
Arthritis, Rheumatoid / immunology
Arthritis, Rheumatoid / physiopathology*
Bone Resorption / immunology
Bone Resorption / physiopathology
Bone Resorption / prevention & control
Cartilage, Articular / immunology
Cartilage, Articular / physiopathology*
Glucocorticoids / pharmacology
Humans
Interleukin-1 / antagonists & inhibitors
Joints / drug effects
Joints / physiopathology
Osteogenesis / drug effects
Osteogenesis / immunology
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Antirheumatic Agents
Glucocorticoids
Interleukin-1
Tumor Necrosis Factor-alpha